<--- Back to Details
First PageDocument Content
Business / Economy / Biotechnology / American brands / Specialty drugs / CAC 40 / Sanofi / Biosimilar / Biopharmaceutical / Janssen Biotech / Fine chemical / Johnson & Johnson
Date: 2016-06-01 15:33:28
Business
Economy
Biotechnology
American brands
Specialty drugs
CAC 40
Sanofi
Biosimilar
Biopharmaceutical
Janssen Biotech
Fine chemical
Johnson & Johnson

Add to Reading List

Source URL: www.dcat.org

Download Document from Source Website

File Size: 300,36 KB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES  What Is a Biopharmaceutical?

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES  What Is a Biopharmaceutical?

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY  What is a Biopharmaceutical?

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document